Skip to main content

Table 1 Survival of the cohort at 1, 5 and 10 years from diagnosis for the total number of cases and for each nosological group

From: Survival of patients with rare diseases: a population-based study in Tuscany (Italy)

 

CASES (n)

Age at diagnosis (mean ± standard deviation)

% males

1 year

95% CI

5 years

95% CI

10 years

95% CI

Peripheral and central nervous system disorders

5928

53.0 ± 21.3

51.6

0.953

0.948–0.959

0.796

0.785–0.807

0.679

0.664–0.694

Congenital anomalies, chromosomal aberrations and genetic syndromesa

2377

17.4 ± 18.2

51.5

0.998

0.995–1.000

0.984

0.977–0.989

0.961

0.949–0.970

Circulatory system diseases

2177

55.4 ± 19.7

35.2

0.982

0.975–0.987

0.917

0.903–0.929

0.800

0.776–0.821

Diseases of the musculoskeletal system and connective tissue

1826

57.3 ± 15.5

18.9

0.973

0.964–0.980

0.892

0.875–0.907

0.768

0.740–0.794

Metabolic diseases

1773

36.7 ± 28.0

58.2

0.962

0.951–0.963

0.899

0.883–0.914

0.845

0.822–0.865

Respiratory diseases

1639

60.1 ± 16.4

57.3

0.947

0.934–0.957

0.719

0.687–0.749

0.565

0.520–0.608

Diseases of the skin and subcutaneous tissue

1413

58.9 ± 22.3

43.9

0.949

0.936–0.960

0.811

0.786–0.833

0.715

0.677–0.748

Diseases of the blood and blood-forming organs

1361

27.9 ± 22.3

48.6

0.992

0.986–0.996

0.972

0.960–0.981

0.962

0.947–0.973

Immune system disorders

1331

38.5 ± 23.0

38.8

0.998

0.994–1.000

0.969

0.956–0.979

0.903

0.875–0.925

Disorders of the eye and adnexa

1301

37.5 ± 18.6

57.3

0.998

0.993–0.999

0.989

0.981–0.994

0.964

0.947–0.975

Endocrine diseases

1036

24.1 ± 20.5

26.7

1.000

0.988

0.976–0.994

0.957

0.933–0.973

Neoplasms

987

31.5 ± 22.7

45.2

0.986

0.977–0.992

0.944

0.926–0.958

0.923

0.899–0.941

Diseases of the genitourinary system

489

43.0 ± 20.5

47.8

0.996

0.983–0.999

0.989

0.971–0.996

0.954

0.907–0.977

Digestive disorders

257

51.1 ± 21.4

53.7

0.968

0.936–0.984

0.896

0.841–0.933

0.818

0.720–0.884

1infectious and parasitic diseases

13

47.2 ± 19.7

53.8

1.000

0.909

0.508–0.987

0.909

0.508–0.987

Total

23,671

44.3 ± 25.0

46.0

0.973

0.9710.975

0.888

0.8840.893

0.808

0.8010.815

  1. Bold is provided for total rare disease survival results
  2. aOnly cases diagnosed beyond 1 month. The total number of cases shown in the table does not refer to the sum of cases for each nosological group. Survival estimates of neonatal morbidities of perinatal origin not shown as only 6 cases were reported. 95% CI 95% confidence interval